Europe Real-Time PCR Market Demonstrates Steady Growth Through 2022 Amid Demand for Rapid, Accurate Molecular Diagnostics
A new industry analysis titled “Europe Real-Time Polymerase Chain Reaction (PCR) Market Size, Share & Trends Analysis Report – By Instrument and Segment Forecasts to 2022” reveals consistent market growth across the European molecular diagnostics landscape. Increased need for precise and time-efficient pathogen detection, cancer screening, and genetic testing continues to drive demand for real-time PCR (RT-PCR) platforms throughout the region.
Market Overview
Real-time PCR is a cornerstone technology in modern diagnostics and biomedical research, enabling the quantification of nucleic acids in real-time with high sensitivity and specificity. Its pivotal role in detecting infectious diseases, monitoring treatment efficacy, and supporting personalized medicine has significantly expanded its market footprint.
Download Sample Pages - https://www.theresearchinsights.com/request_sample?id=14868
Instrument Insights:
The report provides a comprehensive analysis of leading RT-PCR instruments utilized across Europe, including:
-
7500 Real-Time PCR System – A widely adopted instrument for medium-throughput diagnostic labs due to its flexibility and reliability.
-
QuantStudio Dx – Favored in clinical diagnostics for its high sensitivity and IVD compliance.
-
ViiA 7 Dx – Recognized for advanced multiplexing capabilities and customizable workflows in complex research and clinical environments.
-
StepOne/StepOne Plus – Ideal for entry- to mid-level users, offering ease of use and dependable performance.
-
LightCycler 2.0 and LightCycler 480 – Known for their fast cycling times and high-precision fluorescence detection in European academic and hospital labs.
-
Cobas 4800 – Extensively used in virology and oncology testing, especially in centralized diagnostic labs due to its automation and high throughput.
Comments
Post a Comment